NO20006323L - Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse - Google Patents

Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse

Info

Publication number
NO20006323L
NO20006323L NO20006323A NO20006323A NO20006323L NO 20006323 L NO20006323 L NO 20006323L NO 20006323 A NO20006323 A NO 20006323A NO 20006323 A NO20006323 A NO 20006323A NO 20006323 L NO20006323 L NO 20006323L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
derivatives
glycopeptide
glycopeptide derivatives
Prior art date
Application number
NO20006323A
Other languages
English (en)
Other versions
NO326066B1 (no
NO20006323D0 (no
Inventor
J Kevin Judice
Paul Ross Fatheree
Bernice M T Lam
Michael R Leadbetter
Martin Sheringham Linsell
Yongqi Mu
Sean Gary Trapp
Guang Yang
Yan Zhu
Original Assignee
Advanced Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medicine Inc filed Critical Advanced Medicine Inc
Publication of NO20006323D0 publication Critical patent/NO20006323D0/no
Publication of NO20006323L publication Critical patent/NO20006323L/no
Publication of NO326066B1 publication Critical patent/NO326066B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20006323A 1998-12-23 2000-12-12 Glykopeptid-derivater, farmasøytiske sammensetninger samt anvendelser derav. NO326066B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11372898P 1998-12-23 1998-12-23
US12931399P 1999-04-14 1999-04-14
US16402499P 1999-11-04 1999-11-04
US16997899P 1999-12-10 1999-12-10
PCT/US1999/030543 WO2000039156A1 (en) 1998-12-23 1999-12-22 Glycopeptide derivatives and pharmaceutical compositions containing the same

Publications (3)

Publication Number Publication Date
NO20006323D0 NO20006323D0 (no) 2000-12-12
NO20006323L true NO20006323L (no) 2001-02-12
NO326066B1 NO326066B1 (no) 2008-09-08

Family

ID=27493926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006323A NO326066B1 (no) 1998-12-23 2000-12-12 Glykopeptid-derivater, farmasøytiske sammensetninger samt anvendelser derav.

Country Status (23)

Country Link
US (9) US6392012B1 (no)
EP (1) EP1140993B1 (no)
JP (1) JP4362017B2 (no)
KR (1) KR100665204B1 (no)
CN (1) CN1249081C (no)
AT (1) ATE242783T1 (no)
AU (1) AU768204B2 (no)
BR (1) BRPI9914221B8 (no)
CA (1) CA2336445C (no)
CZ (1) CZ301184B6 (no)
DE (1) DE69908819T2 (no)
DK (1) DK1140993T3 (no)
ES (1) ES2201825T3 (no)
HK (1) HK1040721B (no)
HU (1) HU230190B1 (no)
IL (2) IL140093A0 (no)
NO (1) NO326066B1 (no)
NZ (1) NZ508594A (no)
PL (1) PL198311B1 (no)
PT (1) PT1140993E (no)
SI (1) SI1140993T1 (no)
WO (1) WO2000039156A1 (no)
ZA (1) ZA200007222B (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6392012B1 (en) * 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
WO2001057071A2 (en) * 2000-02-04 2001-08-09 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
EP1278549B1 (en) * 2000-05-02 2008-12-10 Theravance, Inc. Composition containing a cyclodextrin and a glycopeptide antibiotic
SI1276759T1 (sl) 2000-05-02 2008-12-31 Theravance Inc Postopek reduktivnega alkiliranja na glikopeptidih
WO2001083520A2 (en) 2000-05-02 2001-11-08 Theravance,Inc Polyacid glycopeptide derivatives
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
AU2001259816A1 (en) 2000-06-22 2002-01-02 Advanced Medecine, Inc. Polyhydroxy glycopeptide derivatives
WO2001098327A2 (en) * 2000-06-22 2001-12-27 Theravance, Inc. Glycopeptide carboxy-saccharide derivatives
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
EP1295711B1 (en) 2001-09-19 2006-04-12 The Procter & Gamble Company A color printed laminated structure, absorbent article comprising the same and process for manufacturing the same
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
US7652039B2 (en) 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
TWI325323B (en) 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
AU2003243574A1 (en) 2002-06-17 2003-12-31 Theravance, Inc. PROCESS FOR PREPARING N-PROTECTED Beta-AMINO ALDEHYDE COMPOUNDS
KR20050047519A (ko) * 2002-07-09 2005-05-20 파스젠, 엘엘씨. 사람 및 동물에서의 미생물 감염의 치료방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003294262B2 (en) * 2002-11-18 2007-08-23 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US7067481B2 (en) * 2003-05-23 2006-06-27 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
ATE388153T1 (de) * 2003-07-11 2008-03-15 Theravance Inc Quervernetzte glycopeptid-cephalosporin- antibiotika
DE102004055582A1 (de) * 2004-11-18 2006-05-24 Bayer Cropscience Ag N-Heterocyclyl-phthalsäurediamide
JP4330169B2 (ja) 2004-11-29 2009-09-16 国立大学法人名古屋大学 グリコペプチド抗生物質モノマー誘導体
US8304597B2 (en) 2004-12-15 2012-11-06 The Procter And Gamble Company Method of using an absorbent article having a functional enhancement indicator
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−(α−アミノ)−ジオール−ジエステル含有ポリ(エステルアミド)およびポリ(エステルウレタン)組成物および使用の方法
JP5178520B2 (ja) 2005-09-22 2013-04-10 メディバス エルエルシー 固体ポリマー送達組成物およびその使用法
US20070173438A1 (en) * 2006-01-13 2007-07-26 The Scripps Research Institute [PSI[CH2NH]PG4] glycopeptide antibiotic analogs
TW200808818A (en) * 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
CN101959849A (zh) * 2007-12-26 2011-01-26 利德治疗公司 作为抗菌剂的新型半合成糖肽
KR20100109934A (ko) 2007-12-26 2010-10-11 시오노기세야쿠 가부시키가이샤 글리코펩티드 항생 물질 배당화 유도체
EP2260060A4 (en) 2008-04-01 2013-01-16 Univ Cornell ORGANIC SOLUBLE CHITOSA SALT AND CHITOSAN DERIVED BIOMATERIALS MANUFACTURED THEREFROM
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN101928330B (zh) * 2009-06-26 2013-10-16 上海来益生物药物研究开发中心有限责任公司 一种新的化合物及其应用
WO2012129493A1 (en) * 2011-03-24 2012-09-27 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
IN2013CH04314A (no) * 2013-09-23 2015-08-28 Jawaharlal Nehru Ct For Advanced Scient Res Jncasr
US20170342110A1 (en) * 2014-12-25 2017-11-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
US20190203240A1 (en) * 2016-01-15 2019-07-04 Universitaet Hamburg Methods for the production of rhamnosylated flavonoids
CA3012176A1 (en) * 2016-01-28 2017-08-03 ACatechol, Inc. Photo-cleavable primer compositions and methods of use
CN107325159A (zh) * 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN107987131B (zh) * 2017-11-16 2021-03-09 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的化合物、其制备方法和应用
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
NL2023883B1 (en) * 2019-09-24 2021-04-26 Univ Leiden Antibiotic compounds
CN111620931B (zh) * 2020-06-12 2021-12-17 苏州博源医疗科技有限公司 万古霉素衍生物及其制备方法和应用
CN114213284B (zh) * 2022-01-04 2023-08-01 丽珠集团福州福兴医药有限公司 (9h-芴-9-基)-癸基(2-氧代乙基)氨基甲酸甲酯及其合成方法
CN121270649A (zh) * 2024-07-03 2026-01-06 烟台新药创制山东省实验室 一类万古霉素衍生物、其制备方法、药物组合物和用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497802A (en) 1983-10-21 1985-02-05 Eli Lilly And Company N-Acyl glycopeptide derivatives
GB8428619D0 (en) 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
US4914187A (en) 1984-11-13 1990-04-03 Gruppo Lepetit S.P.A Ester derivatives of antibiotic L 17046
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
GB8704847D0 (en) 1987-03-02 1987-04-08 Lepetit Spa Substituted alkylamides of teicoplanin compounds
FR2632185B1 (fr) * 1988-06-01 1992-05-22 Rhone Poulenc Chimie Silice pour compositions dentifrices compatible notamment avec le zinc
GB8817397D0 (en) * 1988-07-21 1988-08-24 Lepetit Spa N15-alkyl & n15 n15-di-alkyl derivatives of teicoplanin antibiotics carrying functional groups on alkyl side chain
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ATE134646T1 (de) * 1988-12-27 1996-03-15 Lepetit Spa C63-amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplanine
IE64155B1 (en) 1989-03-29 1995-07-12 Lepetit Spa New substituted alkylamide derivatives of teicoplanin
CA2031803C (en) 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
AU647122B2 (en) 1990-05-28 1994-03-17 Gruppo Lepetit S.P.A. C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992017456A1 (fr) 1991-03-26 1992-10-15 Fujisawa Pharmaceutical Co., Ltd. Derive d'acide amine et sel dudit derive
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
CZ285703B6 (cs) * 1991-07-29 1999-10-13 Biosearch Italia S. P. A. Amidové deriváty antibiotika A 40926
AU703106B2 (en) 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
IT1282586B1 (it) 1996-02-08 1998-03-31 Chemical And Biolog Ind Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli
CA2249323A1 (en) 1996-03-21 1997-09-25 Transcell Technologies, Inc. Solid phase lipoglycopeptide library, compositions and methods
AU2441697A (en) 1996-04-12 1997-11-07 Eli Lilly And Company Covalently-linked glycopeptide dimers
JP4159110B2 (ja) 1996-04-12 2008-10-01 イーライ・リリー・アンド・カンパニー グリコペプチド化合物
KR20000010589A (ko) 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
US5977063A (en) 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5919771A (en) 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5952310A (en) 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
CA2318394A1 (en) 1998-02-20 1999-08-26 Advanced Medicine, Inc. Novel antibacterial agents
JP4307723B2 (ja) 1998-05-01 2009-08-05 イーライ リリー アンド カンパニー N1−修飾グリコペプチド
EP1095058A4 (en) 1998-07-14 2003-07-16 Univ Princeton GLYCOPEPTIDANTIBIOTICS, COMBINATIONAL LIBRARIES OF GLYCOPEPTIDANTIBIOTICS AND METHOD FOR THEIR PRODUCTION
US6392012B1 (en) * 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI325323B (en) 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
ATE388153T1 (de) 2003-07-11 2008-03-15 Theravance Inc Quervernetzte glycopeptid-cephalosporin- antibiotika

Also Published As

Publication number Publication date
NO326066B1 (no) 2008-09-08
PT1140993E (pt) 2003-10-31
DE69908819D1 (de) 2003-07-17
IL140093A (en) 2006-06-11
US7351791B2 (en) 2008-04-01
CN1315961A (zh) 2001-10-03
US7723470B2 (en) 2010-05-25
NO20006323D0 (no) 2000-12-12
HU230190B1 (hu) 2015-09-28
EP1140993B1 (en) 2003-06-11
US6949681B2 (en) 2005-09-27
US6392012B1 (en) 2002-05-21
AU768204B2 (en) 2003-12-04
US6455669B1 (en) 2002-09-24
DK1140993T3 (da) 2003-10-06
JP2002533472A (ja) 2002-10-08
HUP0400887A3 (en) 2012-09-28
NZ508594A (en) 2003-05-30
AU3127300A (en) 2000-07-31
US20090215982A1 (en) 2009-08-27
BRPI9914221B8 (pt) 2021-05-25
BR9914221B1 (pt) 2013-12-31
CA2336445A1 (en) 2000-07-06
EP1140993A1 (en) 2001-10-10
US8030445B2 (en) 2011-10-04
KR20010085857A (ko) 2001-09-07
BR9914221A (pt) 2001-06-26
US20030060598A1 (en) 2003-03-27
US6444786B1 (en) 2002-09-03
JP4362017B2 (ja) 2009-11-11
US6962970B2 (en) 2005-11-08
WO2000039156A1 (en) 2000-07-06
PL198311B1 (pl) 2008-06-30
HUP0400887A2 (hu) 2004-08-30
HK1040721A1 (en) 2002-06-21
SI1140993T1 (en) 2003-12-31
KR100665204B1 (ko) 2007-01-04
CN1249081C (zh) 2006-04-05
ES2201825T3 (es) 2004-03-16
IL140093A0 (en) 2002-02-10
PL348451A1 (en) 2002-05-20
ATE242783T1 (de) 2003-06-15
DE69908819T2 (de) 2004-05-06
US20080103292A1 (en) 2008-05-01
US20040204346A1 (en) 2004-10-14
CZ301184B6 (cs) 2009-12-02
HK1040721B (en) 2003-10-17
US20060241024A1 (en) 2006-10-26
US7101964B2 (en) 2006-09-05
ZA200007222B (en) 2002-03-06
US20050239690A1 (en) 2005-10-27
CA2336445C (en) 2011-07-19
CZ200122A3 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
TR200101126T2 (tr) İkameli fenil türevleri, hazırlanma ve kullanımları
EA200300050A1 (ru) Гликопептидфосфонатные производные
DK1200418T3 (da) Nematodicide trifluorbutener
ES2243579T3 (es) Derivados de pirazolopirideno.
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
BR9813719A (pt) Agentes terapêuticos
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2002248531A1 (en) Pyrazolopyriadine derivatives
DK1073447T3 (da) N1-modificerede glycopeptider
SE9904128D0 (sv) Novel compounds
ATE282608T1 (de) Chinoxalindionen
NO20002321L (no) Bifenylderivater som farmasøytiske midler
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
MY123217A (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DK1390056T3 (da) Glycopeptid-antibiotika
ECSP993299A (es) Derivados glicopeptidicos y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA R&D IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA ANTIBIOTICS IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CUMBERLAND PHARMACEUTICALS INC., US

MK1K Patent expired